register here
Days
Hours
Minutes
Seconds
ERGISTER HERE

About

DigitalHealth.il is Israel's most prestigious annual business conference in the digital health sector. It features leading technologies and serves as the focal point for entrepreneurs, senior healthcare corporate executives, and investors from Israel and abroad. Over the last 5 years, more than 700 participants from the industry attended each event.

As the "start-up nation", Israel is leading innovation hubs in life sciences, information, communication, mobile and cyber technologies. It has years of expertise in implementing health IT, health information exchanges, business analytics and digital health in its healthcare systems and plays a major role in the global digital health landscape.

This year's conference will discuss today’s healthcare systems and their numerous challenges; increased costs, aging population, empowered consumers, fragmented care, and wasted resources.

DigitalHealth.il is Israel's most prestigious annual business conference in the digital health sector. It features leading technologies and serves as the focal point for entrepreneurs, senior healthcare corporate executives, and investors from Israel and abroad. Over the last 5 years, more than 700 participants from the industry attended this event each year.

Israel, as the "start-up nation", is leading innovation hubs in life sciences, information, communication, mobile and cyber technologies. It has years of expertise in implementing health IT, health information exchange, business analytics and digital health in its healthcare systems and plays a major role in the global digital health landscape.

This year's conference will discuss today’s healthcare systems and their numerous challenges; increased costs, aging population, empowered consumers, fragmented care, and wasted resources.

Take a look at what you've missed in previous years:

Organizers:

Sponsors:

Speakers:

Eyal Ben-Yaakov

Life Science Sector Leader,
EY Israel

Allon Bloch

Co-Founder & CEO,
K Health

Sean Day

Research Manager,
Rock Health

Michal Geva

Co-Founder & Managing Partner,
Triventures Management

Dedi Gilad

CEO,
Tyto Care

Yael Glassman

VP Nutrino,
Medtronic

Dr. John Halamka

President Mayo Clinic Platform,
Mayo Clinic

Dr. Eran Harary

VP, Therapeutic Area Head, Neurology & Psychiatry, Global Specialty R&D,
Teva

Ofer Leidner

Co-Founder & President,
Happify Health

Rajeev Ronanki

SVP, Chief Digital Officer,
Anthem

Roy Saar

General Partner,
Mangrove Capital Partner

Avinoam Sapir

SVP, Cluster Head, Israel, Africa, Turkey & Ukraine,
Teva

Balaji Thiagarajan

CTO, CIO, SVP Platforms,
Change Healthcare

Dr. Thomas Tsang

Co-Founder & CEO,
Valera Health

Dr. Benny Zeevi

Managing General Partner,
Tel Aviv Venture Partners

Dr. Eyal Zimlichman

Chief Medical & Innovation Officer,
Sheba Medical Center

Start-up contest judges

Rutie Adar

Head of Samsung Strategy and Innovation Center, Israel,
Samsung Catalyst Fund

Liat Alon

Head of Innovation & CX, Takeda

Assaf Barnea

CEO,
Sanara Ventures

Eyal Ben-Yaakov

Global Service Partner, Life Sciences Sector Leader,
EY Israel

Lia Cromwell

Principal,
Upwest

Mati Gill

Head of Government Affairs Corporate and International Markets,
Teva Pharm

David Gordon

Head of Investments,
Longliv Ventures

Ittai Harel

Managing General Partner,
Pitango

Allen Kamer

Managing Partner,
Qure Ventures

Tamara Mansfeld

Global Innovation Lead,
Pfizer Digital Innovation Lab

Anat Naschitz

Managing Director,
OrbiMed

Michal Rosen

Director,
IBM Research

Dan Shwarzman

CEO,
MindUp

Dorit Sokolov

Managing Director,
Amoon

Dr. Benny Zeevi

Managing General Partner,
Tel Aviv Venture Partners

Yonatan Machado

Investment Director,
Samsung NEXT Ventures

Agenda

22.4.20

Eyal Ben-Yaakov, Life Science Sector Leader, EY Israel

Rajeev Ronanki, SVP & Chief Digital Officer, Anthem

Allon Bloch, Co-Founder & CEO, K Health &  Rajeev Ronanki, SVP & Chief Digital Officer, Anthem

Mental and behavioral health issues are a growing concern in today’s society. In recent years, digital technologies have been developed for diagnosis, treatment and follow-up of those patients. We will discuss their usage, efficacy and disruptive potential.

Moderator: Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners
Speakers: Dr. Eran Harary, VP, Therapeutic Area Head, Neurology & Psychiatry, Global Specialty R&D, Teva
Ofer Leidner, Co-Founder & President, Happify Health
Dr. Thomas Tsang, Co-Founder & CEO, Valera Health

Sean Day, Research Manager, Rock Health

As value based care is taking the U.S. healthcare industry by tying payments of care delivery to the quality of care delivered. This session will describe how Change Healthcare is planning to fundamentally transform and disrupt the healthcare marketplace for financial management.

Balaji Thiagarajan, CTO, CIO, SVP Platforms, Change Healthcare

Though investments in digital health declined in 2019, there are many indicators that the industry is maturing with later stage deals, increased M&A activities and a record number of digital health IPOs. We will explore these trends and others related to financial markets.

Moderator: Michal Geva, Co-Founder & Managing Partner, Triventures Management 

Speakers: Sean Day, Research Manager, Rock Health
Yael Glassman, VP Nutrino, Medtronic
Balaji Thiagarajan, CTO, CIO, SVP Platforms, Change Healthcare
Roy Saar, General Partner, Mangrove Capital Partner

Innovation is a combination of technology, policy, people and process. Mayo Clinic has worked for the past year to create an enabling platform to enhance collaboration and partnerships with emerging digital health companies. In this presentation, the speaker will reflect on the lessons learned, near term priorities and the long-term vision.

Dr. John Halamka, President Mayo Clinic Platform, Mayo Clinic

Healthcare delivery is no longer limited to provider facilities. Empowered patient consumers seek healthcare services in all facets of life. We will explore new methods of healthcare delivery including telehealth, homecare and the hospitals of the future.

Moderator: Dr. Eyal Zimlichman, Chief Medical & Innovation Officer, Sheba Medical Center
Speakers: Dedi Gilad, CEO, Tyto Care
Dr. John Halamka, President Mayo Clinic Platform, Mayo Clinic
Avinoam Sapir, SVP, Cluster Head, Israel, Africa, Turkey & Ukraine, Teva

Moderator: Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners

Speakers: Sean Day, Research Manager, Rock Health
Dr. John Halamka, President Mayo Clinic Platform, Mayo Clinic
Rajeev Ronanki, SVP & Chief Digital Officer, Anthem
Balaji Thiagarajan, CTO, CIO, SVP Platforms, Change Healthcare
Roy Saar, General Partner, Mangrove Capital Partner

REGISTER HERE

22.4.20

Eyal Ben-Yaakov, Life Sciences Sector Leader, EY Israel

Rajeev Ronanki, SVP & Chief Digital Officer, Anthem

Allon Bloch, Co-Founder & CEO, K Health & Rajeev Ronanki, SVP & Chief Digital Officer, Anthem

Mental and behavioral health issues are a growing concern in today’s society. In recent years, digital technologies have been developed for diagnosis, treatment and follow-up of those patients. We will discuss their usage, efficacy and disruptive potential.

Moderator: Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners
Speakers: Dr. Eran Harary, VP, Therapeutic Area Head, Neurology & Psychiatry, Global Specialty R&D, Teva
Ofer Leidner, Co-Founder & President, Happify Health
Dr. Thomas Tsang, Co-Founder & CEO, Valera Health

 

Sean Day, Research Manager, Rock Health

As value based care is taking the U.S. healthcare industry by tying payments of care delivery to the quality of care delivered. This session will describe how Change Healthcare is planning to fundamentally transform and disrupt the healthcare marketplace for financial management.

Balaji Thiagarajan, CTO, CIO, SVP Platforms, Change Healthcare

Though investments in digital health declined in 2019, there are many indicators that the industry is maturing with later stage deals, increased M&A activities and a record number of digital health IPOs. We will explore these trends and others related to financial markets.

Moderator: Michal Geva, Co-Founder & Managing Partner, Triventures Management 


Speakers: Sean Day, Research Manager, Rock Health
Yael Glassman, VP Nutrino, Medtronic
Balaji Thiagarajan, CTO, CIO, SVP Platforms, Change Healthcare
Roy Saar, General Partner, Mangrove Capital Partner

Innovation is a combination of technology, policy, people and process. Mayo Clinic has worked for the past year to create an enabling platform to enhance collaboration and partnerships with emerging digital health companies. In this presentation, the speaker will reflect on the lessons learned, near term priorities and the long-term vision.

Dr. John Halamka, President Mayo Clinic Platform, Mayo Clinic

Healthcare delivery is no longer limited to provider facilities. Empowered patient consumers seek healthcare services in all facets of life. We will explore new methods of healthcare delivery including telehealth, homecare and the hospitals of the future.

Moderator: Dr. Eyal Zimlichman, Chief Medical & Innovation Officer, Sheba Medical Center

Speakers: Dedi Gilad, CEO, Tyto Care
Dr. John Halamka, President Mayo Clinic Platform, Mayo Clinic
Avinoam Sapir, SVP, Cluster Head, Israel, Africa, Turkey & Ukraine, Teva

Moderator: Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners
Speakers: Sean Day, Research Manager, Rock Health
Dr. John Halamka, President Mayo Clinic Platform, Mayo Clinic
Rajeev Ronanki, SVP & Chief Digital Officer, Anthem
Balaji Thiagarajan, CTO, CIO, SVP Platforms, Change Healthcare
Roy Saar, General Partner, Mangrove Capital Partner

ERGISTER HERE
ERGISTER HERE

Past start-up contest winners

Genetika 2019 winners

EfA 2018 winners

Aidoc 2016 winners

6over6 2015 winners

Telesofia 2014 winners

Gallery

Previous
Next

Get in touch

Eyal Ben-Yaakov

Eyal is EY Israel’s Life Sciences Sector Leader based in Tel Aviv, Israel. He has over 20 years of national and global experience serving Growth and Life Sciences clients.
Eyal holds a BA in Accounting from Tel Aviv Management College. He is a Certified Public accountant in Israel. Eyal has been serving as Teva Pharmaceuticals Global Client Service Partner for the last 8 years, leading EY global activities and relationships.

Eyal has served clients in every stage of growth and helped many companies from the early stage through the challenges of launching initial products and establishing a market leader position. Eyal has provided consulting to various Growth and Life Sciences companies on planning strategy, acquisitions, divestitures, due diligence, and post-merger integrations.
He has worked on hundreds of public and private financing, including over 40 IPOs and follow-on offerings.
Eyal’s professional experience includes corporate alliances, spinouts, joint ventures and mergers & acquisitions.

Allon Bloch

Allon Bloch

Allon Bloch is the co-founder and CEO of K Health, a venture-backed health tech company on a mission to empower people with free access to trustworthy health information. A serial entrepreneur, Allon has extensive experience in venture capital and consumer technology. He was co-CEO of Wix, the website publishing platform, co-founder and CEO of Vroom, the largest online car retailer in the US, and CEO of mySupermarket, a digital platform that empowers consumers to find the best prices for their groceries.

He has raised over $300 million in funding from top VCs, corporations, and private equity firms, including Benchmark, Mangrove, Comcast, WPP, Catterton, and T Rowe. Allon is also a former venture capitalist who served as a venture partner at Greylock Partners and general partner at JVP. Earlier in his career, Allon worked as a consultant at McKinsey. He earned his MBA from Columbia Business School.

Sean Day

Sean is the research manager at Rock Health, a market building investor in digital health. Prior to joining the team, Sean worked in R&D operations at Epic, where he helped scale the company’s population health division.
He graduated from Union College with a B.S. in bioengineering and later received his master’s degree in technology policy from the University of Cambridge.

Sean completed the Watson Fellowship in 2015, during which he researched the intersection of technology and culture through perceptions of physical disabilities in developed and developing countries around the world.

Michal Geva

Michal is the Co-Founder and Managing Partner of Triventures and brings over 20 years of executive management experience in medtech and digital health in Israel and the U.S., including ByPass, AST (acquired by Boston Scientific), GI View, TriReme Medical (IPO) and others.

She is the first woman to found and manage a venture capital fund in Israel and was recognized as one of the 50 most influential women in Israel by Globes, Israel’s leading financial journal. With a hands-on approach, Michal is involved in all the fund’s major decisions, leads investments and serves as an active board member in the majority of the portfolio companies.

Dedi Gilad

With over 18 years of leadership positions both in startups as well as global companies, Dedi brings extensive knowledge and hands-on experience in R&D, Marketing and Operations of multi-disciplinary products in the fields of Healthcare IT, Enterprise Systems, Internet and SaaS.

Before founding Tyto Care, Dedi was the General Manager at MDG Medical, VP R&D at WorkplaceIQ (acquired by Siterra / Accruent) and VP R&D at Aman Group. Dedi earned an MBA and a B.Sc. in Industrial Engineering from the Tel-Aviv University.

Yael Glassman

Yael leads Nutrino Health at Medtronic Diabetes Group. As CEO, Yael led Nutrino from market introduction and early revenue to a successful acquisition by Medtronic in 2018.

Previously, Yael held multiple commercial roles: VP of Business Development at Sensible Medical, VP Marketing at Boston based telemedicine leader, American Well and Director care management marketing at TriZetto (acquired by Cognizant). Yael holds a BA in psychology from Hebrew University and an MBA from MIT Sloan of Management.

Dr. John Halamka

John Halamka, M.D., M.S., president of Mayo Clinic Platform, leads a portfolio of platform businesses focused on transforming health care through artificial intelligence, connected health care devices and a network of trusted partners.

Previously, Dr. Halamka was executive director of the Health Technology Exploration Center for Beth Israel Lahey Health, overseeing digital relationships with industry, academia and government. He also was chief information officer at Beth Israel Deaconess Medical Center for more than 20 years. He is a practicing emergency medicine physician.
As the International Healthcare Innovation Professor at Harvard, he helped the George W. Bush administration, the Obama administration and governments worldwide plan health care information strategies.
Dr. Halamka earned his medical degree at the University of California, San Francisco, and pursued graduate work in bioengineering at the University of California, Berkeley.
He has written a dozen technology books, hundreds of articles and thousands of posts on Geekdoctor.

Dr. Eran Harary

Vice President, Therapeutic Area Head of Neurology & Psychiatry in Global R&D at Teva Pharmaceuticals. Eran is also overseeing the Analytics & Big Data initiatives in Teva. He is a medical doctor and a board certified in psychiatry. Eran has more than 15 years-experience in senior global managerial and leadership roles in international large pharmaceutical companies and smaller biotech companies both in Israel and in the US (including Lundbeck Country Medical Diractor, Pfizer Country Medical Director and Pfizer Global Headquarters in New York, USA).

Experienced in world-wide Lifecycle Management of pharmaceuticals from concept through all development stages to post approval. Eran earned his MD degree from the Sackler School of Medicine in Tel Aviv, and later trained and practiced as a psychiatrist at the Chaim Sheba Medical Center, Tel-Hashomer.

Ofer Leidner

As Co-Founder and President of Happify Health, Ofer is an experienced entrepreneur who came into healthcare after spending a decade developing casual games and has a deep expertise in user engagement, gamification and digital delivery platform at scale. Ofer is committed to developing evidence-based therapeutic interventions to treat, manage or improve people’s mental or physical health through meaningful behavior change.

Offered to employers, health plans and pharmaceutical companies, Happify Health’s solutions incorporate behavior therapies, such positive psychology, cognitive behavioral therapy and mindfulness. The company’s clinically-validated digital therapeutic solutions will be FDA-cleared as prescription digital therapies (PDT).
Prior to Happify Health, Ofer co-founded several digital media businesses, including iPlay/Oberon Media, a leading casual gaming company and customer relations software startup, Gate42 Technologies. Ofer holds an MBA in Finance and a B.A. in Economics and Information Technologies, both from Tel Aviv University.

Rajeev Ronanki

Rajeev Ronanki serves as the Chief Digital Officer at Anthem. He is leading Anthem’s transformation to become a digital and AI-first enterprise by harnessing the power of data and platforms to better understand health consumers and provide proactive, personalized care. His experience spans over 20 years of innovation-driven industry and social change across healthcare and technology.

Roy Saar

On a Unicorns hunting spree.
Entrepreneur, Investor and a Social activist.
Was luckily involved in early stage and still serve on the board of WIX.com, WalkMe and other fast growing Israeli start-ups.

Digital Health has intrigued us for a long time with its potential to disrupt and democratize health services.
An early investor at Happify Health, while my partners are involved with K Health and FLO.
Looking for our next investment in the space!

Avinoam Sapir

Avinoam Sapir was appointed CEO of Teva Israel in 2013, and in 2016, he became SVP; Cluster Head in International Markets, responsible for Middle East, Ukraine and South Africa.

In 2015 Avinoam co-founded Sanara Ventures, a Healthcare Innovation Launchpad, JV of Teva and Philips, investing in medical device and digital health ventures. He currently serves as Chairman of the Board. Avinoam holds a BA (Summa Cum Laude) in Economics and Logistics from Bar-Ilan University and an MBA from Tel Aviv University. Before joining Teva, he established and managed a start-up media company, and prior to that served for a decade as a commanding officer in the IDF.

Balaji Thiagarajan

Balaji Thiagarajan is the CTO, CIO & SVP Platforms at Change Healthcare where he leads the healthcare fintech revolution to drive value based outcomes for the Change Healthcare customers. Prior to Change Healthcare, Balaji held several executive leadership roles in some of the leading and emerging global technology companies including Uber, Oracle Microsoft and Google where he helped build the next generation of technologies, infrastructure and platforms.

Throughout his career, Balaji was leading technological transformation in established and emerging industries earning a reputation of creating the most innovative industry leading products. Balaji is also an inventor holding multiple patents in broad band application delivery that enabled Digital Video Recording and Video On Demand for IP based systems.
Balaji holds a MS in Electrical and Computer Engineering from Syracuse University and an MBA from the Wharton School of Business, University of Pennsylvania

Dr. Thomas Tsang

Dr. Thomas Tsang currently serves as CEO and co-founder of Valera Health, a VC backed digital behavioral healthcare start-up delivering high-performing behavioral health services. Valera offers a full-stacked service model powered by a platform that leverages mobile technology to recognize changes in a patient’s conditions and supports meditation to therapy to medication management. Valera is contracted across multiple organizations including Montefiore Health System, Carisk, Northwell Health System and Group Health Wisconsin across several markets.

He was the former Chief Medical Officer at Healthcare Services and Solutions, a Merck subsidiary and helped launched a partnership with Maccabi in Israel. He was also part of the Congressional team that crafted the Affordable Care Act as a staff member for the House Committee on Ways and Means and worked on rolling out pieces of the ACA. He continued his civil service as Senior Advisor to the Governor of Hawaii in 2011.

Dr. Benny Zeevi

Dr. Benny Zeevi is a Managing General Partner at Tel Aviv Venture Partners/ DFJ Tamir Fishman Ventures and Partner at Run Young Capital leads the funds Life Science investments. Prior to joining DFJ TFV in 2003, Dr. Zeevi was the Vice President Business Development & Medical Director of Card Guard AG since 1998. Dr Zeevi was the Co-Chairman of the IATI, Co-Chairman of the IATI Biomed Conference, and currently Co – Chairman of the WHII – 1st and 2nd World Congress on Women’s Health Innovations and Inventions: Addressing Unmet Needs. Dr. Zeevi is deeply involved in the Israeli life sciences and digital health industries.

Dr. Zeevi is the Founder and Co Director of an Executive Program for Biotechnology and Medical Device Entrepreneurs and Managers at the Faculty of Management of Tel-Aviv University. Dr. Zeevi serves as the chairman of the board, a board member and advisory board member of 8 life sciences companies. Dr. Zeevi is a board member of the National Council of Digital Health and Innovation in Healthcare Services at the Ministry of Health, Board Member, Israel National Tissue Bank and board member of Sheba Medical Hospital TTO and ARC Innovation. Dr. Zeevi is a certified Pediatric Cardiologist, specialized in interventional pediatric cardiology.From 1990-1998 he was Director of Pediatric Catheterization Unit, Schneider Children’s Medical Center in Israel. Dr. Zeevi was a fellow and a visiting Professor and part-time clinical staff at the Children’s Hospital, Harvard Medical School in Boston. His credentials include over 70 peer-reviewed scientific and industry articles, in addition to various chapters in textbooks and invited reviews and editorials in pediatric cardiology journals. Dr. Zeevi holds a M.D. degree (Magna Cum Laude) from the Sackler School of Medicine, Tel Aviv University, Israel.

Dr. Eyal Zimlichman

Dr. Eyal Zimlichman is an internal medicine physician, a health care executive and a researcher focused on assessing and improving health care quality and value, patient engagement and patient safety.

Dr. Zimlichman is currently Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center, a top 10 hospital on Newsweek’s list of best hospitals worldwide (2019). Prior to this Dr. Zimlichman has held the position of Lead Researcher at Partners Health Care Clinical Affairs Department in Boston where he was involved in the efforts to bring about a strategic care redesign initiative.

Dr. Zimlichman is a founding member of the International Academy of Quality and Safety in Health Care. Dr. Zimlichman is a graduate of the Harvard School of Public Health Executive Health Care Management Master of Science program and has earned his MD at the Technion Israel Institute of Technology in Haifa, Israel.

Eyal Ben-Yaakov

Eyal is EY Israel’s Life Sciences Sector Leader based in Tel Aviv, Israel. He has over 20 years of national and global experience serving Growth and Life Sciences clients.
Eyal holds a BA in Accounting from Tel Aviv Management College. He is a Certified Public accountant in Israel. Eyal has been serving as Teva Pharmaceuticals Global Client Service Partner for the last 8 years, leading EY global activities and relationships.

Eyal has served clients in every stage of growth and helped many companies from the early stage through the challenges of launching initial products and establishing a market leader position. Eyal has provided consulting to various Growth and Life Sciences companies on planning strategy, acquisitions, divestitures, due diligence, and post-merger integrations.
He has worked on hundreds of public and private financing, including over 40 IPOs and follow-on offerings.
Eyal’s professional experience includes corporate alliances, spinouts, joint ventures and mergers & acquisitions.